Dialysis solution having at least one osmotic agent

US11090388B2 · kind B2 · utility

Assignees

• Fresenius Medical Care Deutschland GmbH · DE
• Friedrich-Schiller-Universitat Jena · DE

Inventors

• Thomas Heinze · Finnentrop, DE
• Robert Hampe · Jena, DE
• Robert Berlich · Namborn, DE
• Lisa Finkler · Nonnweiler, DE
• Jens Lothar Burkhart · Sankt Ingbert, DE

Key dates

• Filing date: Nov 14, 2016
• Grant date: Aug 17, 2021
• Expiry date: Nov 14, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a dialysis solution having at least one osmotic agent, with the osmotic agent being a polysaccharide modified by 2-sulfoethyl groups.